What is Solifenacin?
Solifenacin is a tablet you’ll take every day to treat an overactive bladder. It relaxes the muscles around your bladder walls, which allows it to hold more urine. It also prevents sudden and involuntary bladder contractions. This means you should need to use the bathroom less frequently, and with less urgency.
How does Solifenacin work?
Solifenacin is a type of muscarinic receptor antagonist. Muscarinic receptors are located on the smooth muscle surrounding the walls of your bladder, and tell these muscles to contract when activated by a neurotransmitter called acetylcholine.
Solifenacin binds to these receptors so acetylcholine can’t, which inhibits the contraction of the muscles around your bladder, keeping them relaxed. While relaxing muscles might sound counter-productive if you’re struggling with overactive bladder, it actually means your bladder can hold more urine before you need to go, and helps to prevent sudden, involuntary contractions.[1]
How do Solifenacin doses work?
Solifenacin tablets come in two doses: a 5 mg and 10 mg tablet. You’ll normally start on the 5 mg tablet, and if you’re feeling good with side effects, your doctor might move you up to 10 mg. We only offer the 5 mg tablet, but if your clinician recommends that you move up to 10 mg, you can just take two tablets per dose.
What is Solifenacin’s active ingredient?
Solifenacin is a generic medicine. It’s named after its active ingredient, solifenacin succinate. It’s a time of muscarinic receptor antagonist, which means it binds to muscarinic receptors on the smooth muscle around your bladder to prevent these muscles from contracting. This helps to manage symptoms of overactive bladder, like the frequent and sudden urge to urinate.
How we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.